These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2496143)

  • 1. Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.
    Cassatella MA; Hartman L; Perussia B; Trinchieri G
    J Clin Invest; 1989 May; 83(5):1570-9. PubMed ID: 2496143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon.
    Gupta JW; Kubin M; Hartman L; Cassatella M; Trinchieri G
    Cancer Res; 1992 May; 52(9):2530-7. PubMed ID: 1568222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
    Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Immunodefic Rev; 1988; 1(1):55-69. PubMed ID: 3078710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components.
    Condino-Neto A; Whitney C; Newburger PE
    J Immunol; 1998 Nov; 161(9):4960-7. PubMed ID: 9794432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic granulomatous disease. Molecular genetics.
    Dinauer MC; Orkin SH
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
    Ruggiero V; Tavernier J; Fiers W; Baglioni C
    J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
    Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE
    Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.
    Newburger PE; Ezekowitz RA; Whitney C; Wright J; Orkin SH
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5215-9. PubMed ID: 2839835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation.
    Thelen M; Wolf M; Baggiolini M
    J Clin Invest; 1988 Jun; 81(6):1889-95. PubMed ID: 2838524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation of the human myeloid cell line, ML3, by tumour necrosis factor and interferon-gamma is accompanied by enhanced expression of the CD4 protein and messenger RNA.
    Cassatella MA; Trinchieri G; Hassan NF; Hartman L; Sorio C; Berton G
    Immunology; 1992 May; 76(1):55-9. PubMed ID: 1628901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Drapier JC; Wietzerbin J; Hibbs JB
    Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
    Buscema M; Todd I; Deuss U; Hammond L; Mirakian R; Pujol-Borrell R; Bottazzo GF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
    Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ
    J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of verapamil on the class I major histocompatibility complex antigen expression in K562 chronic myelogenous leukemia cells treated with recombinant human interferon-gamma.
    Takemura Y; Koide Y; Miyachi H; Shibata T; Sekiguchi S
    Cancer Lett; 1992 Aug; 65(2):99-106. PubMed ID: 1511424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic effects of tumor necrosis factor alone and in combination with gamma-interferon on tumor biopsies in clonogenic assay.
    Salmon SE; Young L; Scuderi P; Clark B
    J Clin Oncol; 1987 Nov; 5(11):1816-21. PubMed ID: 3119787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.